Growth Metrics

Conmed (CNMD) Total Liabilities (2016 - 2026)

Conmed filings provide 17 years of Total Liabilities readings, the most recent being $1.3 billion for Q1 2026.

  • On a quarterly basis, Total Liabilities fell 1.73% to $1.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.3 billion, a 1.73% decrease, with the full-year FY2025 number at $1.3 billion, down 3.79% from a year prior.
  • Total Liabilities hit $1.3 billion in Q1 2026 for Conmed, roughly flat from $1.3 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $1.6 billion in Q3 2022 to a low of $996.2 million in Q1 2022.
  • Median Total Liabilities over the past 5 years was $1.4 billion (2022), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Total Liabilities: soared 58.28% in 2022 and later dropped 9.59% in 2024.
  • Conmed's Total Liabilities stood at $1.6 billion in 2022, then dropped by 5.56% to $1.5 billion in 2023, then fell by 8.34% to $1.3 billion in 2024, then fell by 3.79% to $1.3 billion in 2025, then increased by 0.36% to $1.3 billion in 2026.
  • The last three reported values for Total Liabilities were $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025) per Business Quant data.